Walmart and Target will report earnings next week, providing fresh insight into how Americans are faring shortly after retail ...

Shares in global vaccine makers and drugmakers fell on Friday after U.S. President-elect Donald Trump picked Robert F.

Should Kennedy win Senate confirmation, critics say a radical antiestablishment medical movement would take power.

With President-elect Donald Trump returning to the White House, a changing of the guard at the Federal Trade Commission (FTC) ...

The nonprofit partnered with MullenLowe to develop a campaign based on data from its biannual customer and patient experience ...

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

Source: Sanofi Besides health initiatives, Sanofi has executed campaigns that ... Self-care unlocks potential of fast-moving consumer healthcare in Vietnam The wave of self-care in Vietnam allows ...

Sanofi’s decision to cancel the spin-off ... Its healthcare solutions are available in more than 180 countries worldwide. Consumer Health Company (Opella) (Sold-Out entity) Headquartered in ...

The sale comes as Sanofi aims to accelerate its R&D investments and increase focus on its biopharma business. The move reflects a wider trend across the industry, with several major pharma companies ...

Sanofi has entered exclusive negotiations to sell a 50% controlling stake in its consumer health business, Opella, to the US private equity firm Clayton, Dubilier & Rice (CD&R). Opella ...

Sanofi Consumer Health Care India Ltd, the pharmaceutical company that makes Combiflam among other consumer drugs, announced to sell 26% of its equity shares to Opal Bidco SAS along with U.S ...

The drugmaker this week raised its annual profit forecast when announcing exclusive negotiations with US buyout firm Clayton Dubilier & Rice for the sale of its consumer health unit. Chief executive ...